Clinical Trial

Complete Remission After Treatment With Biologics for Nasal Polyps

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In this RCT the investigators randomize patients who are treated with biologic treatment (Nucala or Dupixent) due to nasal polyps and have controlled disease within the last year to either stop treatment og continue as a control group.
Trial Details
NCT Number NCT07268313
Lead Sponsor Rigshospitalet, Denmark
Conditions Nasal Polyps
Enrollment 66 participants
Start Date 2025-04-03
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-05